Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA in NPC
Zevra Therapeutics (ZVRA) says it will present new long-term real-world data on MIPLYFFA® for Niemann-Pick disease type C (NPC) at the 2026 SSIEM Annual Symposium.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.